In contrast, B7-H3, a novel immune checkpoint protein, is highly expressed in sarcomatoid histology; if ongoing trials are effective in terms of improving overall survival, this could become the optimal treatment for this type of mesothelioma. This evidence concerns the gene CD276 and mesothelioma.